Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Anti-Cancer Medicines Availability: International Study

AntiNeoplastics Medicines Availability study International banner

The ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe was published in Annals of Oncology in September 2017.

Study objectives

  • To provide national health authorities with data on the availability of licensed anti-neoplastic medicines across Europe so that they can decide how to best resolve the challenges identified
  • To report on the actual availability of anti-neoplastic medicines to patients when they are prescribed and when patients can afford them
  • To map the international situation, particularly in view of recent medicines shortages of some common, affordable, medically necessary anti-cancer medicines

Study results

The ESMO study mapped the international variation on the out-of-pocket costs and availability of cancer medicines in particularly in view of recent medicines shortages of some common, affordable, medically necessary anti-cancer medicines, including those on the WHO Model List of Essential Medicines. In addition, it revealed that limited national resources pose a formidable barrier to expensive, innovative medicines which can provide gains in non-curative settings.

International presentations

Find out about the international presentations of this study here.

Coordinating partners

This ESMO was conducted under the auspices of the ESMO Global Policy Committee in collaboration with the:

Collaborating partners

Collaborators

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings